EMLA cream provides rapid pain relief for the curettage of molluscum contagiosum in children with atopic dermatitis without causing serious application-site reactions

Pediatric Dermatology

Volumn 15, Issue 4, 1998, Pages 309-312

  Rönnerfält, Lena ^a   Fransson, Jessica ^b   Wahlgren, Carl Fredrik ^b,c  

^a Betaniastiftelsen Hospital   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EMLA;

ANALGESIA; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CURETTAGE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; MOLLUSCUM CONTAGIOSUM; PAIN ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; TOPICAL DRUG ADMINISTRATION; WOUND DRESSING;

ANESTHETICS, COMBINED; ANESTHETICS, LOCAL; CHILD; CHILD, PRESCHOOL; CURETTAGE; DERMATITIS, ATOPIC; FEMALE; HUMANS; LIDOCAINE; MALE; MOLLUSCUM CONTAGIOSUM; OCCLUSIVE DRESSINGS; OINTMENTS; PAIN; PREOPERATIVE CARE; PRILOCAINE; TIME FACTORS;

EID: 0031877741     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.1998.1998015309.x     Document Type: Article

References (16)

1. Hurwitz S. Clinical pediatric dermatology. Philadelphia: WB Saunders, 1993:338-340.
2. Juhlin L, Evers H, Broberg F. A lidocaine-prilocaine cream for superficial skin surgery and painful lesions. Acta Derm Venereol (Stockh) 1980;60:544-546.
3. Rosdahl I, Edmar B, Gisslén H, Nordin P, Lillieborg S. Curettage of molluscum contagiosum in children: analgesia by topical application of a lidocaine/prilocaine cream (EMLA). Acta Derm Venereol (Stockh) 1988;68:149-153.
4. Wagner G, Mensing H. Perkutane anästhesie durch anwendung einer lidocain-prilocain-creme (EMLA-creme 5%) - erfahrungen bei der therapie multipler mollusca contagiosa im kindesalter. Akt Dermatol 1989;15:44-46.
5. de Waard-van der Speck FB, Oranje AP, Lilliborg S, Hop WCJ, Stolz E. Treatment of molluscum contagiosum using a lidocaine/prilocaine cream (EMLA) for analgesia. J Am Acad Dermatol 1990;23:685-688.
6. Vieluf D, Ruzicka T. Complications and diseases associated with atopic eczema. In: Ruzicka T, Ring J, Przybilla B, eds. Handbook of atopic eczema. Berlin-Heidelberg: Springer-Verlag, 1991:54-79.
7. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Derm Venereol (Stockh) 1980;92 suppl:44-47.
8. ® cream): comparison with placebo cream and no local premedication. Acta Anaesthesiol Stand 1987;31: 735-739.
9. Goodenough B, Addicoat L, Champion GD, et al. Pain in 4-to 6-year-old children receiving intramuscular injections: a comparison of the faces pain scale with other self-report and behavioral measures. Clin J Pain 1997;13:60-73.
10. Aps C, Reynolds F. The effect of concentration of vasoactivity of bupivacaine and lignocaine. Br J Anaesth 1976; 48:1171-1174.
11. Johns RA, DiFazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology 1985;62:141-144.
12. Juhlin L, Rollman O. Vascular effects of a local anesthetic mixture in atopic dermatitis. Acta Derm Venereol (Stockh) 1984;64:439-440.
13. de Waard-van der Speck FB, Oranje AP. Purpura caused by EMLA is of toxic origin. Contact Dermatitis 1997;36: 11-13.
14. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1985;65:102-105.
15. Rajka G. Essential aspects of atopic dermatitis. Berlin-Heidelberg: Springer-Verlag, 1989:181-196.
16. Haugstvedt S, Friman AM, Danielson K. Plasma concentrations of lidocaine and prilocaine and analgesic effect after dermal application of EMLA cream 5% for surgical removal of mollusca in children. Z Kinderchir 1990;45: 148-150.